Acadian Asset Management LLC Supernus Pharmaceuticals, Inc. Transaction History

Acadian Asset Management LLC

$32.2 Billion
Q3 2024

A detailed history of Acadian Asset Management LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 1,363 shares of SUPN stock, worth $49,735. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,363

Holding current value

$49,735

% of portfolio

0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$25.77 - $35.16 $35,124 - $47,923	1,363 New	1,363 $42,000
Q2 2021 Aug 11, 2021	SELL	$26.72 - $33.19 $354,253 - $440,033	-13,258 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$24.15 - $31.45 $3.99 Million - $5.2 Million	-165,331 Reduced 92.58%	13,258 $347,000
Q4 2020 Feb 11, 2021	SELL	$17.7 - $25.81 $4.23 Million - $6.17 Million	-238,872 Reduced 57.22%	178,589 $4.49 Million
Q3 2020 Nov 09, 2020	SELL	$20.2 - $25.05 $5.12 Million - $6.35 Million	-253,454 Reduced 37.78%	417,461 $8.7 Million
Q2 2020 Aug 12, 2020	BUY	$17.09 - $24.89 $4.28 Million - $6.23 Million	250,467 Added 59.57%	670,915 $15.9 Million
Q1 2020 May 11, 2020	BUY	$14.45 - $24.69 $21,949 - $37,504	1,519 Added 0.36%	420,448 $7.57 Million
Q4 2019 Feb 06, 2020	SELL	$19.93 - $29.13 $2.17 Million - $3.16 Million	-108,646 Reduced 20.59%	418,929 $9.94 Million
Q3 2019 Nov 07, 2019	SELL	$25.47 - $33.37 $1.55 Million - $2.03 Million	-60,826 Reduced 10.34%	527,575 $14.5 Million
Q2 2019 Aug 08, 2019	SELL	$29.96 - $38.87 $4.37 Million - $5.67 Million	-145,997 Reduced 19.88%	588,401 $19.5 Million
Q1 2019 May 09, 2019	BUY	$32.77 - $41.99 $306,858 - $393,194	9,364 Added 1.29%	734,398 $25.7 Million
Q4 2018 Feb 07, 2019	SELL	$30.84 - $49.51 $4.56 Million - $7.32 Million	-147,856 Reduced 16.94%	725,034 $24.1 Million
Q3 2018 Oct 30, 2018	SELL	$42.7 - $56.55 $10.6 Million - $14.1 Million	-249,115 Reduced 22.2%	872,890 $44 Million
Q2 2018 Jul 24, 2018	SELL	$44.1 - $59.85 $812,057 - $1.1 Million	-18,414 Reduced 1.61%	1,122,005 $67.2 Million
Q1 2018 Apr 12, 2018	SELL	$37.15 - $46.9 $5.19 Million - $6.55 Million	-139,760 Reduced 10.92%	1,140,419 $52.2 Million
Q4 2017 Jan 18, 2018	BUY	$36.4 - $42.6 $891,472 - $1.04 Million	24,491 Added 1.95%	1,280,179 $51 Million
Q3 2017 Oct 13, 2017	BUY	$36.75 - $49.65 $46.1 Million - $62.3 Million	1,255,688	1,255,688 $50.2 Million

Others Institutions Holding SUPN

# of Institutions

282

Shares Held

60.9M

Call Options Held

27.7K

Put Options Held

11.3K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.95B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account

Acadian Asset Management LLC Supernus Pharmaceuticals, Inc. Transaction History